ArticleCancers2019
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.
Sarah Richtmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papercites it
ArticleCancers2019
Sarah Richtmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.